Compare MIND & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIND | NSPR |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 81.8M |
| IPO Year | 1994 | N/A |
| Metric | MIND | NSPR |
|---|---|---|
| Price | $8.35 | $1.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 267.9K | 57.8K |
| Earning Date | 12-09-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $46,195,000.00 | $7,779,000.00 |
| Revenue This Year | N/A | $22.76 |
| Revenue Next Year | $8.08 | $75.45 |
| P/E Ratio | $23.86 | ★ N/A |
| Revenue Growth | 2.21 | ★ 14.04 |
| 52 Week Low | $4.45 | $1.59 |
| 52 Week High | $14.50 | $3.80 |
| Indicator | MIND | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 43.71 |
| Support Level | $8.65 | $1.74 |
| Resistance Level | $9.39 | $1.95 |
| Average True Range (ATR) | 0.58 | 0.16 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 44.88 | 33.33 |
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.